Coordinated litigation involving injuries allegedly caused by AndroGel (testosterone gel) continues to move forward in a federal court in Illinois, with early trials tentatively scheduled to begin in late 2016. A case management plan created by the judge overseeing the litigation outlines a process by which bellwether trials will be selected and a potential calendar for trial dates.
Free AndroGel Lawsuit Evaluation: If you or a loved one was injured by AndroGel, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of the testosterone supplement and we can help.
Testosterone Multidistrict Litigation (MDL)
In June 2014, a multidistrict litigation (MDL) was established in Illinois federal court for lawsuits alleging injuries from testosterone replacement therapy (TRT) supplements. MDLs are created when there are multiple cases with similar statements of fact, in order to streamline the litigation process for all parties involved. When the testosterone MDL was first established, there were less than 50 cases included. Today, U.S. District Judge Matthew Kennelly is overseeing more than 223 such lawsuits, and many experts predict this number will grow into the thousands before the litigation is complete.
Side Effects of Testosterone
The practice of testosterone supplementation has grown immensely over the past decade, with a flood of new creams, gels, patches and injections. Marketing campaigns promote these “Low T” products for a variety of generalized symptoms such as lowered sex drive, decreased energy levels and even weight gain. In light of the growing use of testosterone supplements, as well as reports of serious cardiovascular side effects linked to the drugs, the U.S. Food & Drug Administration (FDA) announced earlier this year it had launched an investigation into the safety of prescription testosterone boosters.
Meanwhile, a large number of testosterone users around the country have filed product liability lawsuits seeking compensation for their injuries. Plaintiffs in these cases allege that testosterone supplements caused them to have severe cardiovascular side effects, including heart attacks, strokes and pulmonary embolisms (blood clot trapped in the lungs). Additionally, plaintiffs allege that testosterone manufacturers failed to adequately warn about the cardiovascular risks associated with their products. While the defendants include several different companies, most of the complaints have been filed against Abbott Laboratories and AbbVie, Inc.
AndroGel Bellwether Trial Selection
On November 6, Judge Kennelly filed a case management order that outlines the process by which a half-dozen bellwether trials will be selected. Although these cases will only include complaints over AndroGel, findings in the trials could affect lawsuits against other testosterone manufacturers as well. The first three bellwether trials are scheduled to begin in October 2016, with the final trials being completed around April 2017.
Can I File an AndroGel Lawsuit?
Only a qualified attorney can determine whether you are eligible to file an AndroGel Lawsuit, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.
Most cases involving pharmaceuticals allege that a product was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a potential side effect. In the case of AndroGel, our attorneys suspect that patients may be able to take legal action in light of claims that manufacturers failed to adequately warn doctors and patients about the risk of cardiovascular side effects including heart attack, stroke, blood clot, pulmonary embolism and death.
How Can Filing a Lawsuit Help Me?
By filing an AndroGel Lawsuit, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your injury, as well as for damages for pain and suffering. Additionally, filing a lawsuit can help hold the bone cement’s manufacturer accountable for releasing an allegedly defective product into the marketplace, and to discourage other pharmaceutical companies from engaging in similar conduct.